Primary Sources: Operation Delirium : The New Yorker
Sent via Flipboard
Sent from my iPhone
Additional films from the Edgewood program now online
WAR OF THE MIND...
Sent from my iPhone
I was unable to write my usual-type blog post this week, but I did managed to get a few words down.
For people everywhere, can there be a more tear-soaked weekend than this.
From: "Eiser, Arielle" <aeiser@APA.ORG>Date: December 14, 2012 3:17:51 PM ESTSubject: [DIVOFFICERS] URGENT: NEW GRADUATE PSYCHOLOGY EDUCATION (GPE) CYCLE ANNOUNCED-APPLICATIONS DUE BY FEBRUARY 8TH!Reply-To: "Eiser, Arielle" <aeiser@APA.ORG>
Posted Date: December 7, 2012
Open Date: (Earliest Submission Date) February 21, 2013
Application Due Date: March 21, 2013 , by 5:00 PM local time of applicant organization.
AIDS Application Due Date: March 21, 2013
Earliest Start Date September 2013
This Funding Opportunity Announcement (FOA) solicits Research Project Grant (R01) applications addressing exceptionally novel hypotheses and/or remarkably difficult problems in neuroscience and disorders of the nervous system. This announcement is for support of new rather than ongoing projects, and is not intended for pilot research. The proposed research may have a high risk of failure, but it must promise results with especially high impact should it be successful. The research should be groundbreaking, innovative, original and/or unconventional, with the potential to solve important problems or open new areas for investigation
National Institute of Neurological Disorders and Stroke (NINDS)
Before submitting an application, it is extremely important to verify that the proposed research is of interest to at least one of the NIH Institutes that is participating in this FOA, since applications that are not germane to the mission of one or more of the participating Institutes will not be reviewed. Applicants are encouraged to contact the appropriate Institute representative listed in the FOA to ensure that the proposed research will be responsive to this FOA. Applicants are strongly advised to include a cover letter indicating the appropriate Institute. Please see FOA for details at: http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-13-007.html
TO UNSUBSCRIBE: send email to firstname.lastname@example.org<mailto:email@example.com>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive confirmation email if successful. If you have problems contact firstname.lastname@example.org 301-435-1309
People dealing with substance abuse often have trouble dealing with conflicts. I thought, therefore, that some division 28 members might get a kick out of the following:
Man, that Charles Schultz was a genius when it comes to intrapersonal conflicts!
It has been said that until we learn to deal wisely with our own intrapersonal conflicts, we will be lacking in our ability to resolve conflicts with others.
"...Decades after a risky Cold War experiment, a scientist lives with secrets. ..."http://www.newyorker.com/reporting/2012/12/17/121217fa_fact_khatchadourian?currentPage=allThis is a riveting story of army supported psychopharmacology at Edgewood Arsenal.
There will be a Joint Meeting of the National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board on December 13, 2012, 11:30 a.m. – 1:00 p.m. ET. Dr. Lawrence Tabak, Principal Deputy Director, National Institutes of Health (NIH), will provide an overview of the Trans-NIH Substance Use, Abuse, and Addiction Functional Integration Plan. Please note, the public is welcome to join the call 1-888-324-8014 (toll-free); Passcode is 4418818
Webmeeting: http://webmeeting.nih.gov/suaa/. Attached for your information is a copy of the open agenda. The public is also invited to submit additional comments to SUAAinfo@nih.gov through Friday, December 28, 2012. Best regards,
Jane E. Smither
Office of Science Policy and Communications
National Institute on Drug Abuse/NIH
6001 Executive Boulevard
Room 5230 MSC 9591
Bethesda, MD 20892-9591
Telephone - (301) 443-6071
Fax - (301) 443-6277
E-mail - email@example.com
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Joint Meeting of the
National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board
December 13, 2012
11:30 a.m. to 1:00 p.m. ET
1-888-324-8014 (toll-free); Passcode is 4418818
Thursday, December 13, 2012 - OPEN
11:30 a.m. Call to Order
Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH
Review of Policy and Procedures
Justin D. Hentges, M.P.P., Special Assistant to the Principal Deputy Director, NIH
11:35 a.m. Overview of the Trans-NIH Substance Use, Abuse, and Addiction Integration Plan
Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH
12:05 p.m. Council Discussion
12:45 p.m. Public Comments*
1:00 p.m. Adjourn
*The public is invited to submit additional comments to SUAAinfo@nih.gov through Friday, December 28, 2012. The comments will be shared with the three Committees
You are receiving this message because you are part of The Association for the Treatment of Tobacco Use and Dependence (ATTUD) Listserv. To send a message to the entire listserv, send the email to ATTUD@LISTSRV.UCSF.EDU. To reply to a message to the entire listserv, please use "Reply All," and to respond individually to the email sender, use "Reply." This listserv is not moderated. Unless specifically stated, messages posted on this listserv represent only the views of the individuals posting the messages, and ATTUD does not endorse the accuracy of any "statements."
Use this link to unsubscribe from this mailing list.
TO UNSUBSCRIBE: send email to firstname.lastname@example.org<mailto:email@example.com>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful.
If you have problems contact firstname.lastname@example.org 301-435-1309
The National Institute on Drug Abuse (NIDA) at the National Institutes of Health is an agency of the United States Department of Health and Human Services
Great opportunity- see below:
Spend a year working on Capitol Hill
APA seeks applications for its Congressional Fellowship Program. This opportunity allows up to two psychologists to spend a year in Washington, D.C., where they receive first-hand experience with federal policymaking. Congressional Fellows work as special legislative assistants in congressional member or committee offices and engage in a diverse range of policymaking activities. APA offers specialized Congressional Fellowships for midcareer professionals, experts in health and behavior issues, and developmental psychologists and clinicians with experience working with children. The program offers a year-long stipend and funds to support relocation, travel, and the purchase of health insurance. For more information, visit http://www.apa.org/about/gr/fellows or call the Public Interest Government Relations Office at 202.336.5935.
Applications must be postmarked by Jan. 11, 2013.
Experimental and Clinical Psychopharmacology will publish a Special Issue focused on Psychopharmacology of Attention: The Impact of Drugs in an Age of Increased Distractions in October 2013. The goal of this special issue is to highlight progress made during the past 15 years in understanding how licit and illicit drugs impact attention within the context of prevailing contemporary distractions. Topics such as distracted driving, social networking, animal and human models of multitasking, and attention-deficit/hyperactivity disorder are just a few of the areas of relevance to this special issue.
Laboratories engaged in research in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this Special Issue. Please contact the Guest Editor, Dr. Anthony Liguori, or the Editor, Dr. Suzette Evans, directly (see below) with your topic, a draft title and a draft abstract before submitting your manuscript. These will also us to create a dynamic and diverse issue on these topics. Manuscripts should be submitted as usual through the APA Online Submission Portal, and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the Special Issue on Psychopharmacology of Attention. While we cannot guarantee that your submission will be accepted for inclusion in the final published special section, we hope that you will consider submitting a manuscript for this Special Issue. Manuscripts received no later than February 15, 2013 will be considered for inclusion in the Special Issue.
Questions or inquiries about the Special Issue can be directed to the Guest Editor of the issue, Anthony Liguori, Ph.D., at email@example.com or the Editor, Suzette M. Evans, Ph.D., at firstname.lastname@example.org.
The Planning Committee for the first-ever Division 28/50 Annual Conference recognizes that the holiday season is a
busy one and has extended the deadline for Breakout Sessions to December 15, 2012. Please take a moment to consider
submitting a proposal AND please forward to colleagues to do the same. Presenting in the same program along with Dr. Shiffman
and Dr. Sullivan is quite an hour, and so will be presenting at the INAUGURAL conference! Don’t miss out!